• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状RNA_0057209作为竞争性内源RNA,通过促进STK4介导的Hippo信号通路并吸附微小RNA-183来抑制甲状腺癌进展。

Circular RNA_0057209 Acts as ceRNA to Inhibit Thyroid Cancer Progression by Promoting the STK4-Mediated Hippo Pathway Sponging MicroRNA-183.

作者信息

Peng Xinzhi, Zhu Yue, Lin Shaojian, Yu Weiming, Zhang Cheng, Tan Langping, Long Miaoyun, Luo Dingyuan, Ji Chengcheng

机构信息

Department of Thyroid Surgery, The Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.

Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China.

出版信息

Oxid Med Cell Longev. 2022 Mar 11;2022:9974639. doi: 10.1155/2022/9974639. eCollection 2022.

DOI:10.1155/2022/9974639
PMID:35308166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8933075/
Abstract

Thyroid cancer is the most common malignancy of the endocrine system, and its outcome remains unsatisfactory. In recent years, circular RNAs (circRNAs) have emerged as crucial regulators in cancers. In the current study, we aimed to investigate whether and how circRNA_0057209 functioned in thyroid cancer. Initial results revealed that circRNA_0057209 and STK4 were both reduced, while miR-183 was up-regulated in thyroid cancer tissues and cells. Experiments including RNA pull-down and RIP assays further identified that upregulation of circRNA_0057209 augmented the expression of STK4, a target gene of miR-183, by competitively-binding to miR-183. Furthermore, functional experiments provided evidence that overexpression of circRNA_0057209 not only inhibited the proliferative, migratory, and invasive properties of thyroid cancer cells while facilitating their apoptosis but also delayed tumor growth. Conversely, upregulation of miR-183 or silencing of STK4 reversed the changes induced by circRNA_0057209. Meanwhile, mechanistic experimentation demonstrated that circRNA_0057209 promoted STK4 expression by sponging miR-183, while STK4 enhanced YAP phosphorylation to mediate the Hippo pathway, thereby suppressing tumor progression. Altogether, our findings indicated that circRNA_0057209 may serve as a competing endogenous RNA of miR-183 to increase STK4 expression, thus inhibiting the development of thyroid cancer.

摘要

甲状腺癌是内分泌系统最常见的恶性肿瘤,其治疗效果仍不尽人意。近年来,环状RNA(circRNA)已成为癌症中的关键调节因子。在本研究中,我们旨在探究circRNA_0057209在甲状腺癌中是否发挥作用以及如何发挥作用。初步结果显示,在甲状腺癌组织和细胞中,circRNA_0057209和STK4均降低,而miR-183上调。包括RNA下拉和RIP分析在内的实验进一步证实,circRNA_0057209的上调通过与miR-183竞争性结合,增强了miR-183靶基因STK4的表达。此外,功能实验表明,circRNA_0057209的过表达不仅抑制了甲状腺癌细胞的增殖、迁移和侵袭特性,促进了其凋亡,还延缓了肿瘤生长。相反,miR-183的上调或STK4的沉默逆转了circRNA_0057209诱导的变化。同时,机制实验证明,circRNA_0057209通过吸附miR-183促进STK4表达,而STK4增强YAP磷酸化以介导Hippo通路,从而抑制肿瘤进展。总之,我们的研究结果表明,circRNA_0057209可能作为miR-183的竞争性内源性RNA来增加STK4表达,从而抑制甲状腺癌的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/804612ed6944/OMCL2022-9974639.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/966d95c6a3a8/OMCL2022-9974639.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/8df7dee35ab1/OMCL2022-9974639.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/7602202edc39/OMCL2022-9974639.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/f1d4d35db00f/OMCL2022-9974639.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/5877f39ff5cc/OMCL2022-9974639.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/4f4ff11230db/OMCL2022-9974639.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/24f87ccf5a48/OMCL2022-9974639.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/00f5339cd44d/OMCL2022-9974639.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/804612ed6944/OMCL2022-9974639.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/966d95c6a3a8/OMCL2022-9974639.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/8df7dee35ab1/OMCL2022-9974639.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/7602202edc39/OMCL2022-9974639.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/f1d4d35db00f/OMCL2022-9974639.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/5877f39ff5cc/OMCL2022-9974639.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/4f4ff11230db/OMCL2022-9974639.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/24f87ccf5a48/OMCL2022-9974639.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/00f5339cd44d/OMCL2022-9974639.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/8933075/804612ed6944/OMCL2022-9974639.009.jpg

相似文献

1
Circular RNA_0057209 Acts as ceRNA to Inhibit Thyroid Cancer Progression by Promoting the STK4-Mediated Hippo Pathway Sponging MicroRNA-183.环状RNA_0057209作为竞争性内源RNA,通过促进STK4介导的Hippo信号通路并吸附微小RNA-183来抑制甲状腺癌进展。
Oxid Med Cell Longev. 2022 Mar 11;2022:9974639. doi: 10.1155/2022/9974639. eCollection 2022.
2
Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.长链非编码 RNA TNRC6C-AS1 通过 Hippo 信号通路促进 STK4 的甲基化,从而抑制甲状腺癌细胞凋亡和自噬。
J Cell Mol Med. 2020 Jan;24(1):304-316. doi: 10.1111/jcmm.14728. Epub 2019 Oct 27.
3
CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.环状 CCNA1 沉默作为 miR-106b-5p 的海绵吸附物抑制 GPM6A 表达,通过增强 DYNC1I1 表达和激活 AKT/ERK 信号通路促进 HCC 进展。
Int J Biol Sci. 2022 Jan 1;18(2):637-651. doi: 10.7150/ijbs.66915. eCollection 2022.
4
Suppression of long non-coding RNA TNRC6C-AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway.长链非编码 RNA TNRC6C-AS1 通过 Hippo 信号通路抑制 DNA 去甲基化来保护甲状腺癌中的 STK4。
Cell Prolif. 2019 May;52(3):e12564. doi: 10.1111/cpr.12564. Epub 2019 Apr 1.
5
METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.METTL3 诱导的 miR-222-3p 上调抑制 STK4 并促进甲状腺癌细胞的恶性行为。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):474-490. doi: 10.1210/clinem/dgab480.
6
Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1.敲低 microRNA-103a-3p 通过上调 LATS1 抑制 Hippo 信号通路抑制甲状腺癌细胞的恶性行为。
Neoplasma. 2020 Nov;67(6):1266-1278. doi: 10.4149/neo_2020_191224N1331. Epub 2020 Aug 4.
7
CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.环状 RNA-104718 通过 microRNA-218-5p/TXNDC5 信号通路作为竞争性内源性 RNA 促进肝癌进展。
Clin Sci (Lond). 2019 Jul 15;133(13):1487-1503. doi: 10.1042/CS20190394.
8
The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.新型 circCLK3/miR-320a/FoxM1 轴促进宫颈癌进展。
Cell Death Dis. 2019 Dec 12;10(12):950. doi: 10.1038/s41419-019-2183-z.
9
CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346.环状 RNA HACE1 通过吸附 miR-346 来上调 Tfcp2L1,从而作为竞争性内源性 RNA 抑制分化型甲状腺癌的进展。
Endocr J. 2021 Aug 28;68(8):1011-1025. doi: 10.1507/endocrj.EJ20-0806. Epub 2021 Jun 4.
10
CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.环状 RNA_0058063 通过靶向 miR-486-3p/FOXP4 轴在膀胱癌进展中发挥 ceRNA 作用。
Biosci Rep. 2020 Mar 27;40(3). doi: 10.1042/BSR20193484.

引用本文的文献

1
ARHGAP36 serves as a diagnostic and therapeutic marker that mediates immune escape and promotes thyroid cancer metastasis.ARHGAP36作为一种诊断和治疗标志物,介导免疫逃逸并促进甲状腺癌转移。
Biomed Rep. 2025 Jun 12;23(2):137. doi: 10.3892/br.2025.2015. eCollection 2025 Aug.
2
Dysregulated Expression Patterns of Circular RNAs in Cancer: Uncovering Molecular Mechanisms and Biomarker Potential.癌症中环状RNA的表达模式失调:揭示分子机制和生物标志物潜力
Biomolecules. 2024 Mar 22;14(4):384. doi: 10.3390/biom14040384.
3
Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer.

本文引用的文献

1
MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.微小 RNA-18a 靶向 STK4/MST1 肿瘤抑制因子对于 HPV 阳性宫颈癌的转化是必要的。
PLoS Pathog. 2020 Jun 18;16(6):e1008624. doi: 10.1371/journal.ppat.1008624. eCollection 2020 Jun.
2
SIRT1 Regulates N -Methyladenosine RNA Modification in Hepatocarcinogenesis by Inducing RANBP2-Dependent FTO SUMOylation.SIRT1 通过诱导 RANBP2 依赖性 FTO SUMOylation 调节肝癌发生中的 N -甲基腺苷 RNA 修饰。
Hepatology. 2020 Dec;72(6):2029-2050. doi: 10.1002/hep.31222. Epub 2020 Oct 22.
3
Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p.
环状RNA在调控甲状腺癌特征中的新作用。
Cancer Gene Ther. 2024 Apr;31(4):507-516. doi: 10.1038/s41417-024-00736-0. Epub 2024 Feb 5.
4
MicroRNA-183 cluster: a promising biomarker and therapeutic target in gastrointestinal malignancies.微小RNA-183簇:胃肠道恶性肿瘤中有前景的生物标志物和治疗靶点。
Am J Cancer Res. 2023 Dec 15;13(12):6147-6175. eCollection 2023.
5
The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer.N6-甲基腺苷 RNA 修饰在甲状腺癌中的新兴作用。
Eur J Med Res. 2023 Nov 1;28(1):475. doi: 10.1186/s40001-023-01382-2.
6
Circular RNA EIF3I promotes papillary thyroid cancer progression by interacting with AUF1 to increase Cyclin D1 production.环状RNA EIF3I通过与AUF1相互作用增加细胞周期蛋白D1的产生,从而促进甲状腺乳头状癌进展。
Oncogene. 2023 Oct;42(43):3206-3218. doi: 10.1038/s41388-023-02830-3. Epub 2023 Sep 11.
7
CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K-Akt pathway and epithelial-mesenchymal transition.环状 RNA 家族 1 促进甲状腺乳头状癌细胞的进展,通过与 CSNK2A1 相互作用来激活 PI3K-Akt 通路和上皮-间充质转化。
J Endocrinol Invest. 2023 Mar;46(3):545-557. doi: 10.1007/s40618-022-01928-x. Epub 2022 Oct 28.
8
MicroRNA-124 modulates neuroinflammation in acute methanol poisoning rats via targeting Krüppel-like factor-6.微小 RNA-124 通过靶向 Kruppel 样因子 6 调节急性甲醇中毒大鼠的神经炎症。
Bioengineered. 2022 May;13(5):13507-13519. doi: 10.1080/21655979.2022.2078549.
Hsa_circ_0011385通过靶向miR-361-3p促进甲状腺癌进展。
Cancer Cell Int. 2020 Feb 13;20:49. doi: 10.1186/s12935-020-1120-7. eCollection 2020.
4
Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.长链非编码 RNA TNRC6C-AS1 通过 Hippo 信号通路促进 STK4 的甲基化,从而抑制甲状腺癌细胞凋亡和自噬。
J Cell Mol Med. 2020 Jan;24(1):304-316. doi: 10.1111/jcmm.14728. Epub 2019 Oct 27.
5
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.甲状腺癌的靶向治疗:激酶抑制剂及其他。
Endocr Rev. 2019 Dec 1;40(6):1573-1604. doi: 10.1210/er.2019-00007.
6
Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.激活的 hippo 信号通路抑制 NK/T 细胞淋巴瘤细胞的增殖并促进其凋亡。
Cancer Med. 2019 Jul;8(8):3892-3904. doi: 10.1002/cam4.2174. Epub 2019 May 23.
7
Circular RNAs: an emerging landscape in tumor metastasis.环状RNA:肿瘤转移领域的新进展
Am J Cancer Res. 2019 Apr 1;9(4):630-643. eCollection 2019.
8
Suppression of long non-coding RNA TNRC6C-AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway.长链非编码 RNA TNRC6C-AS1 通过 Hippo 信号通路抑制 DNA 去甲基化来保护甲状腺癌中的 STK4。
Cell Prolif. 2019 May;52(3):e12564. doi: 10.1111/cpr.12564. Epub 2019 Apr 1.
9
Circular RNA: a novel biomarker and therapeutic target for human cancers.环状 RNA:人类癌症的新型生物标志物和治疗靶点。
Int J Med Sci. 2019 Jan 1;16(2):292-301. doi: 10.7150/ijms.28047. eCollection 2019.
10
Evolving Understanding of the Epidemiology of Thyroid Cancer.甲状腺癌流行病学认识的演变。
Endocrinol Metab Clin North Am. 2019 Mar;48(1):23-35. doi: 10.1016/j.ecl.2018.10.002. Epub 2018 Dec 23.